Infinity Pharmaceuticals Technical Analysis

Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.28  0.12  5%

Infinity Pharmaceuticals Inc retains Downside Deviation of 11.7, Market Risk Adjusted Performance of (0.13) and Risk Adjusted Performance of 0.0633. Infinity Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with intention to determine a pattern that calculates the direction of the corporation future prices. In other words you can use this information to find out if the corporation will indeed mirror its model of historical price patterns or the prices will eventually revert. We found nineteen technical drivers for Infinity Pharmaceuticals which can be compared to its competitors. Please check out Infinity Pharmaceuticals Treynor Ratio, and the relationship between Standard Deviation and Downside Variance to decide if Infinity Pharmaceuticals is priced fairly providing market reflects its last-minute price of 2.28 per share. Please also validate Infinity Pharmaceuticals Total Risk Alpha which is currently at (13.49) to confirm the company can sustain itself at future point.
Investment Horizon     30 Days    Login   to change

Infinity Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Infinity Pharmaceuticals Inc. You can use it to identify possible trend reversals for Infinity Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Infinity Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Infinity Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Infinity Pharmaceuticals Inc applied against its price change over selected period. The best fit line has a slop of 0.098971 % which means Infinity Pharmaceuticals Inc will continue generating value for investors. It has 34 observation points and a regression sum of squares at 7.99, which is the sum of squared deviations for the predicted Infinity Pharmaceuticals price change compared to its average price change.

Did you try this?

Run Portfolio Quick Import Now

Portfolio Quick Import

Import or update all your transactions via one easy-to-use interface
Hide  View All  Next  Launch Portfolio Quick Import
Infinity Pharmaceuticals Inc is currently regarded as number one stock in mean deviation category among related companies. It is currently under evaluation in standard deviation category among related companies creating about  1.96  of Standard Deviation per Mean Deviation. The ratio of Standard Deviation to Mean Deviation for Infinity Pharmaceuticals Inc is roughly  1.96